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ARTICLE OPEN
Group-2 innate lymphoid cell-dependent regulation of tissue
neutrophil migration by alternatively activated
macrophage-secreted Ear11
Veera Panova1,5, Mayuri Gogoi1, Noe Rodriguez-Rodriguez1, Meera Sivasubramaniam1, Helen E. Jolin1, Morgan W. D. Heycock1,
Jennifer A. Walker1, Batika M. J. Rana1, Lesley F. Drynan1, Michael Hodskinson1, Richard Pannell1, Gareth King1, Mark Wing1,
Andrew J. Easton2, Caroline A. Oedekoven3, David G. Kent3,6, Padraic G. Fallon4, Jillian L. Barlow1,6 and Andrew N. J. McKenzie 1
Type-2 immunity is characterised by interleukin (IL)-4, IL-5 and IL-13, eosinophilia, mucus production, IgE, and alternatively activated
macrophages (AAM). However, despite the lack of neutrophil chemoattractants such as CXCL1, neutrophils, a feature of type-1
immunity, are observed in type-2 responses. Consequently, alternative mechanisms must exist to ensure that neutrophils can
contribute to type-2 immune reactions without escalation of deleterious inflammation. We now demonstrate that type-2 immune-
associated neutrophil infiltration is regulated by the mouse RNase A homologue, eosinophil-associated ribonuclease 11 (Ear11),
which is secreted by AAM downstream of IL-25-stimulated ILC2. Transgenic overexpression of Ear11 resulted in tissue neutrophilia,
whereas Ear11-deficient mice have fewer resting tissue neutrophils, whilst other type-2 immune responses are not impaired.
Notably, administration of recombinant mouse Ear11 increases neutrophil motility and recruitment. Thus, Ear11 helps maintain
tissue neutrophils at homoeostasis and during type-2 reactions when chemokine-producing classically activated macrophages are
infrequently elicited.
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INTRODUCTION
The cytokines interleukin (IL)-25 and IL-33 are released rapidly by
epithelial cells in the lungs1,2 and intestine3,4 in response to type-2
immunity-inducing stimuli, such as allergens and helminthic
parasites. These molecules drive type-2 immune responses,
promoting the secretion of IL-4, IL-5, IL-9, and IL-13 initially from
group 2 innate lymphoid cells (ILC2s),5–7 and subsequently from T
helper 2 (Th2) cells.8,9 This promotes eosinophilia, mucus produc-
tion, smooth muscle contraction, IgE class switching in B cells, and
alternatively activated macrophages (AAM). These responses are
required for the robust and timely elimination of parasitic helminth
infections in the gut, promoting repair and immune homoeostasis,
but also for mediating inappropriate immune activation to
allergens. By contrast highly pro-inflammatory pathogen-elicited
type-1 immune responses, driven by IFN-γ and TLR ligation, activate
classically activated macrophages (CAM) leading to their production
of inflammatory cytokines, nitric oxide and chemokines such as
CXCL1 that recruit neutrophils to sites of microbial infection.
However, even during immune homoeostasis and induced type-2
responses neutrophils are observed without the development of
overt type-1 immunity. This suggests that alternative mechanisms
exist to recruit and maintain neutrophils in the absence of type-1
stimulation.
During type-2 immunity macrophages respond to IL-4 and IL-
13, derived from ILC2s in the innate phase of the response, and
express a characteristic alternatively activated profile with high
levels of Arginase 1, Relmα, Ym-1, and Ym-2.10 AAMs have been
implicated in responses associated with repair and metabolic
functions, but also in immune pathology. Interestingly, these
AAMs also help maintain immune homoeostasis by counteracting
inflammatory immune activation characterised by CAM.10 Thus,
stimulation of AAM or CAM pathways contribute to maintaining
the balance of repair and anti-microbial immunity, and potential
immune-mediated pathology.
Although many studies have demonstrated a role for AAMs in
tissue remodelling and wound repair, by promoting proliferation
and collagen production in fibroblasts,11–13 there is evidence that
AAMs are also able to perform other functions, including activation
of T helper cell subsets and pathogen/host cell killing.14 However,
since AAMs have been shown to be only weakly phagocytic,15 the
exact mechanism by which they induce pathogen killing is unclear,
and it has been suggested that they also recruit neutrophils
to specific tissue sites.10,16 Indeed, it has been reported that AAMs
and neutrophils collaborate to kill Strongyloides stercoralis in a
complement-dependent manner.17 In addition, lung macrophages
taken from mice 45 days post Nippostrongylus brasiliensis infection,
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and transferred to naive animals, promoted parasite clearance from
the worm-infected recipients via a mechanism dependent on ‘N2’
neutrophils (characterised by Arg1, Chi3l3, and Retnla expression).18
Neutrophil accumulation, promoted by the chitinases Ym1 and
Ym2, has also been reported to contribute to N. brasiliensis-induced
lung injury.19 However, the pathways that govern the presence of
neutrophils at sites of type-2 inflammation are understudied, and
though a number of factors have been proposed, including the
chemokine CCL2,20 IL-5,21 IL-17A, and Ym1,19 their mechanism of
action, in some cases, remains to be determined.
We observed that intranasal IL-25 treatment, in addition to
inducing eosinophilic inflammation also resulted in a concurrent
neutrophil infiltration, which coincided with an increase in
expression of the mouse RNaseA paralogue, eosinophil-associated
ribonuclease 11 (Ear11). Murine eosinophil-associated ribonu-
cleases (Ear) molecules are paralogues of human eosinophil
cationic protein (ECP) and eosinophil-derived neurotoxin (EDN),
and are associated with asthma.22–24 Assays have suggested
diverse roles including chemotactic,25 bactericidal,26 anti-viral,27,28,
and anti-helminthic29 activities in vitro. Notably, transgenic
overexpression of Ear11 in mice resulted in augmented neutrophil
development in the bone marrow, and neutrophilic infiltrates in
the tissues. Furthermore, naive Ear11-deficient mice had fewer
neutrophils in the spleen and lungs, and this specific deficit
remained following allergen and worm challenge, while other
type-2 immune responses were not impaired. IL-25-dependent
expression of Ear11 was restricted to AAM, was induced by IL-4
and IL-13 treatment, and was ILC2-dependent, with ILC2-deficient
mice (Roraflox/floxIl7raCre) also showing decreased neutrophilia
following IL-25 administration. Mechanistically, administration of
recombinant mouse Ear11 (rmEar11) to wild-type mice rapidly
recruited neutrophils to the peritoneal cavity. Our data support a
novel in vivo role for Ear11 in maintaining tissue neutrophils
during homoeostasis and type-2 reactions when differentiation of
classical neutrophil chemoattractant-producing macrophages
would not normally be promoted.
RESULTS
IL-25 induces concomitant tissue eosinophil and neutrophil
infiltration in the lungs
Although IL-25 and IL-33 are primarily potent initiators of
eosinophilia,30,31 we and others have also observed IL-25-induced
neutrophil infiltration in the lungs of mice administered with IL-25
intranasally (Fig. 1a).30,32 Time-course analysis also showed a rapid
influx of neutrophils in response to IL-33 stimulation (Supplementary
Fig. 1a), similar to neutrophil infiltration reported previously in the
peritoneal cavity.33 Since there is no report of IL-25 receptor
expression on neutrophils we performed microarray analysis to
study gene expression data from lung tissues exposed to IL-25 and
IL-33 to identify potential candidate molecules that could underlie
neutrophil infiltration. IL-25 and IL-33 both induced robust
upregulation of a number of known type-2 associated molecules,
including Clca3, Muc5ac, Chi3l3, Chi3l4, Itln1, and the chemokines
Ccl11, and Ccl17.34 In addition, a number of genes with less well-
known type-2 function were also upregulated. One of the most
highly upregulated genes was Ear11,34 a homologue of RNase A,
and a paralogue of ECP and EDN. Human EDN and ECP are induced
by type-2 immunity22–24 and have been reported to possess
chemotactic activities in vitro.25 Furthermore, Ear11 has been
proposed to act in vitro as a chemoattractant for macrophages.35
Although mouse Ear11 expression has been reported in lung
alveolar macrophages in models of allergic asthma and following
the administration of IL-25 or IL-33, little is known about the
functional roles of Ear11 in vivo. To investigate the spatial expression
of Ear11 following the induction of type-2 immune responses,
tissues were harvested after intranasal administration of either
IL-25 or IL-33. Ear11 transcription, determined using quantitative
reverse-transcription (RT-PCR), was significantly induced in bone
marrow, spleen, and lung, and expression was comparable between
IL-25- and IL-33-treated tissue (Fig. 1b and Supplementary Fig. 1b).
Overexpression of Ear11 results in an increased tissue neutrophilia
Given the broad tissue distribution of Ear11 gene expression we
generated transgenic mice with ubiquitous Ear11 overproduc-
tion (Supplementary Fig. 2a). Two founder lines were produced
and Ear11 overexpression verified (Supplementary Fig. 2b, c).
Strikingly, Ear11Tg mice from both lines were noticeably smaller
than wild-type littermates (Supplementary Fig. 2d), failed to
thrive and did not breed. In addition, post mortem analysis
revealed abnormalities in tissue morphology, such as small
thymi, enlarged hearts, and gall bladders (Supplementary Fig. 2e).
In an effort to circumvent the growth abnormalities observed in
the Ear11Tg mice and more clearly delineate a role for Ear11
production by haematopoietic cells we generated haematopoie-
tic chimaeras with bone marrow harvested from the Ear11Tg
founders (Supplementary Fig. 2f). Sub-lethally irradiated B6SJL
mice (CD45.1) were reconstituted with 100% C57BL/6 (CD45.2)
bone marrow (B6SJL:C57BL/6 mice), or Ear11Tg (CD45.2) bone
marrow (B6SJL:Ear11Tg mice).
B6SJL:Ear11Tg chimaeric mice displayed elevated Ear11 expression
in multiple tissues arising from the transferred bone marrow, and
failed to gain weight in the 6 weeks post bone marrow cell
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Fig. 1 Ear11 expression is associated with the induction of the
type-2 response by IL-25. IL-25 was given intranasally on three
consecutive days and lung tissue was analysed. a Flow cytometric
analysis of eosinophil (Ly6GintSiglecF+) and neutrophil (Ly6GhighSi-
glecF−) infiltration. PBS used as a control. Percentage of cells taken
from LiveCD45+CD11c− gate. Data pooled from two independent
experiments (n= 4–5). b qPCR determination of Ear11 in bone
marrow, spleen, and lung after three doses of IL-25. Data
representative of two independent experiments (n= 4).
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reconstitution, as compared with B6SJL:C57BL/6 controls (Supple-
mentary Fig 2g, h). Notably, this correlated with neutrophil infiltration
in the lung and spleen (Fig. 2a, b), whereas other inflammatory cells,
including T cells and eosinophils, were unchanged (Supplementary
Fig. 2i–k). Furthermore, although bone marrow eosinophils
(CD45.2+CD11b+CD19−SSChighLy6GlowSiglecF+) and neutrophils
(CD45.2+CD11b+CD19−SSChighLy6GhighSiglecF-) were identified but
unchanged in the B6SJL:C57BL/6, an unexpected population of
Ly6GintSiglecFlo cells was observed in the bone marrow of the B6SJL:
Ear11Tg chimaeras (Fig. 2c, d). This was not due to dysfunctional
myeloid development, as assessed by colony forming unit analysis
(Supplementary Fig. 2l). Taken together these data indicate an
unexpected role for haematopoietic cell-derived Ear11 in regulating
neutrophilia in vivo.
Ear11 is produced by monocytes, macrophages, and DCs following
type-2 provocation in vivo
To examine Ear11-dependent pathways and its function in
neutrophil homoeostasis and recruitment, an Ear11 reporter
mouse strain was generated by replacing the coding region of
the Ear11 gene with a cassette encoding the mCherry
fluorescent protein (Supplementary Fig. 3a). The integration of
mCherry created a null Ear11 allele with breeding to homo-
zygosity producing an Ear11-deficient mouse (Ear11Ch/Ch)
(Supplementary Fig. 3b). We established the absence of Ear11
transcripts (Supplementary Fig. 3c, d), and corroborated Ear11
protein deficiency in Ear11Ch/Ch mice compared with wild-type
controls, using antibodies raised against rmEar11 (Supplemen-
tary Fig. 4a–e). Pilot studies in naive and type-2 challenged mice
did not show any gross difference in Ear11mCherry expression
between Ear11+/Ch mice and Ear11Ch/Ch mice (data not shown),
thus although we cannot completely rule out that absence of
Ear11 may alter cell expression patterns the available data do
not suggest any abnormality.
In naive Ear11mCherry reporter mice, or mice treated with PBS,
Ear11mCherry expression was detected in CD45+ Lin (CD3 CD4
CD8 CD19 Gr-1)– CD11b+ Ly6C+ CD115+ monocytes in bone
marrow and spleen, and at lower levels in blood monocytes and
lung dendritic cells (Fig. 3a, b and Supplementary Fig. 5a–d).
Ear11+/Ch mice were then treated intraperitoneally or intranasally
with PBS or IL-25 to induce a type-2 immune response. IL-25
facilitated a significant increase in Ear11mCherry expression
in multiple tissues including bone marrow, lung, spleen and
blood (Fig. 3b and Supplementary Fig. 5a–d). Ear11mCherry+
cells in the bone marrow, spleen and blood conformed to a
monocyte phenotype, being CD45+ Lin (CD3 CD4 CD8 CD19
Gr-1)– CD11b+ Ly6C+ CD115+ (Fig. 3b and Supplementary
Fig. 5a–d). In the lung, Ear11mCherry expression was observed
in CD45+CD11c+F4/80+ alveolar macrophages and in a popula-
tion of CD45+CD11c+CD11b+MHCIIhigh dendritic cells (Fig. 3b
and Supplementary Fig. 5d). Confocal microscopy of frozen
spleen sections indicated Ear11mCherry+ cells in small clusters
that localised to the splenic red pulp, and not to the T, B, or
marginal zones (Fig. 3c).
To investigate the expression of Ear11 during type-1 and
type-2 immune responses Ear11mCherry reporter mice were
challenged with a number of physiologically relevant immune
polarising stimuli. Ragweed pollen (RWP) allergen, when
administered intranasally to reporter mice, induced Ear11-
mCherry in alveolar macrophages (Fig. 3d), localised to the
sub-mucosa, away from the basement membrane of the large
airways (Fig. 3e). In addition, N. brasiliensis infection or intranasal
Alternaria alternata extract challenge induced Ear11mCherry
expression in lung alveolar macrophages and dendritic cells,
respectively (Fig. 3f, Supplementary Fig. 5e, f). By contrast,
infection with pneumonia virus of mice (PVM), an enveloped
ssRNA—virus that infects lung tissue, and is closely related
to human respiratory syncytial virus, failed to induce Ear11-
mCherry+ cells (Supplementary Fig. 5g). Similarly, Ear11-
mCherry+ cells were not induced in mice treated intranasally
with lipopolysaccharide (LPS), a potent inducer of type-1
immunity (Supplementary Fig. 5h).
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Fig. 2 Transgenic overexpression of Ear11 (Rnase2a) causes neutrophil infiltration. a Inflammation (black arrows) in the lungs of bone
marrow chimaeras was analysed in H&E stained, paraffin-embedded sections (×20 magnification, 20 μm scale bar). b Neutrophil numbers
assessed by flow cytometry in the lung and spleen of bone marrow chimaeras. c, d Flow cytometry plots and graphed data showing analysis
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C57BL/6 or Ear11Tg bone marrow (BM). Data representative of two independent experiments, n= 4–7.
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Together, these data indicate that Ear11 expression is upregu-
lated during type-2 immunity, but not type-1 immune responses,
and is restricted to the myeloid lineage.
IL-4, IL-13, and ILC2 are required for Ear11 expression by
alternatively activated macrophages
The association of Ear11 expression with myeloid cells in type-2
immunity specifically raised the possibility that Ear11 may
represent a product of AAMs that arises in response to type-2
cytokine stimulation. Relmα and Arginase 1 are markers of AAM.36
Both IL-25 and IL-33 induced Relmα and Arginase 1 expression by
lung alveolar macrophages (Supplementary Fig. 6a). IL-25-induced
Ear11mCherry-positive and -negative alveolar macrophages were
isolated and assessed for markers of alternative activation. The
Ear11mCherry+ macrophages were highly restricted to the Retnla
(Relma)-positive, Arg1-positive AAM population (Fig. 4a). Similarly,
IL-33 induced Ear11mCherry+ macrophages also showed higher
expression of AAM signature genes (Supplementary Fig. 6b, c).
To understand whether IL-25 could directly induce Ear11
expression, or if this was mediated by cytokines downstream of
IL-25, such as IL-4 and IL-13, peritoneal macrophages were
purified from naive Ear11+/Ch mice and cultured with media or
the recombinant cytokines IL-25, IL-33, IL-13, and IL-4. IL-25 and
IL-33 did not induce Ear11, whilst only a modest induction was
caused by IL-13, as assessed by Ear11mCherry production
(Fig. 4b), the detection of Ear11 mRNA (Fig. 4c), and Ear11
protein expression (Fig. 4d). By contrast, treatment with IL-4
rapidly upregulated Ear11 (Fig. 4b–d). Ear11 expression by
Fig. 3 Ear11mCherry is expressed in monocytes, macrophages, and DCs during a type-2 response. a Flow cytometric analysis of
Ear11mCherry expression in naive Ear11+/+ and Ear11+/Ch and b mice treated intraperitoneally (bone marrow, spleen, and blood) or
intranasally (lung) as indicated (see Supplementary Fig. 5a–d for gating). Representative of 2–3 independent experiments (with 3–4 mice per
experiment). c Confocal microscopy of spleen sections from Ear11+/Ch mice treated intraperitoneally as shown (2 independent experiments,
n= 4). Top row shows the marginal (blue) and B cell zones (green). Middle row depicts T cell (yellow) and B cell (green) zones labelling the
white pulp of the spleen (bottom row shows enlargement of Ear11mCherry expression in PBS and cytokine-stimulated spleen). ×20
magnification, 100 μm scale bar. d Flow cytometric analysis of CD45+CD11c+F4/80+ alveolar macrophages and e confocal microscopy of lung
taken from Ear11+/+ and Ear11Ch/Ch mice treated intranasally with PBS or RWP. e Airways and blood vessels stained with smooth muscle actin
(SMA, green); all nuclei were counterstained with DAPI (blue). Two independent experiments, n= 5–8; ×20 magnification with ×63 inset,
50 μm scale bar. f Ear11mCherry expression in CD45+CD11c+F4/80+ alveolar macrophages on day 32 post infection with N. brasiliensis by flow
cytometry (data representative of two independent experiments, n= 4–7).
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macrophages was not induced by culture with IL-5, IFN-γ, or TLR
1–9 agonists (data not shown).
Since the induction of Ear11 occurs within 24 h of IL-25
treatment,34 we assessed whether IL-4 and IL-13-producing
ILC2 were required for Ear11 expression and IL-25-induced
neutrophil infiltration.5 ILC2-deficient (Roraf/fIl7raCre) and
Il7raCre control mice,8 were treated intranasally with two
consecutive doses of IL-25 and 24 h later lung CD45+CD11c+Si-
glecF+F4/80+ macrophages were sorted and tested for Ear11
expression by qPCR. Whilst IL-25 administration resulted in
highly elevated levels of Ear11 in macrophages purified from
Il7raCre control mice, there was a near absence of Ear11
expression in macrophages derived from the ILC2-deficient
mice (Fig. 4e). Furthermore, the absence of ILC2 also resulted in
reduced neutrophil infiltration as compared with ILC2-sufficient
controls upon IL-25 challenge, without affecting homoeostatic
neutrophil numbers (Fig. 4f, Supplementary Fig. 6d). Interest-
ingly, complementation of IL-25 challenge with rmEar11 was not
sufficient to induce neutrophil recruitment in the lung of ILC2-
deficient mice (Fig. 4g).
These results demonstrate that the inducer cytokine IL-25 does
not directly induce Ear11 in AAMs, but instead induces IL-4 and
IL-13. This likely occurs via an ILC2-dependent mechanism. In turn,
IL-4/IL-13-induced AAM upregulate Ear11 production and indu-
cing IL-25-dependent lung neutrophilia.
Ear11 is required to maintain neutrophil homoeostasis in tissues
Complementing the previous observations, we found that naive
Ear11Ch/Ch mice had reduced numbers of neutrophils and
macrophages in the lung, spleen, blood, and bone marrow in
contrast to the increased neutrophilia observed in the Ear11Tg
mice (Fig. 5a–c). In line with neutrophil reduction, we observed
decreased numbers of bone marrow promyelocytes and
granulocyte–monocyte progenitors (as previously defined37),
suggesting a potential role of Ear11 in neutrophil development
(Supplementary Fig. 6e). CD4 T cells, CD8 T cells, B cells, ILC2,
eosinophils, mast cells, basophils, common myeloid progenitors
(CMPs) populations were all normal (data not shown).
Previous studies suggesting an association between Ear11 and
lung allergy imply a potential role in type-2 inflammation.38
Therefore, wild-type and Ear11-deficient mice were next treated
intranasally with IL-25 for two consecutive days and 24 h after the
last treatment tissues were analysed. In contrast to wild-type mice,
Ear11Ch/Ch mice did not show increased neutrophil infiltration in
the bronchoalveolar lavage (BAL) (Fig. 5d). In addition, wild-type
mice and Ear11Ch/Ch were treated with RWP extract for 5
consecutive days before analysis of the tissues 24 h after the last
treatment. As expected, RWP treatment increased the numbers of
macrophages in wild-type mice, and although the absence of
Ear11 did not alter the numbers of macrophages significantly, we
did observe fewer neutrophils in the lungs of the Ear11Ch/Ch mice
Fig. 4 Ear11mCherry is expressed preferentially by alternatively activated macrophages. a Expression of Ear11, Retnla (Relma), and Arg1 by
alveolar Ear11-negative or Ear11-positive macrophages sorted from Ear11+/Ch mice treated with intranasal IL-25. Assessed by qPCR. b Ear11+/Ch
expression by peritoneal macrophages (CD45+CD11b+F4/80+) cultured in a time-course in either media alone or media supplemented with
rmIL-25, rmIL-33, rmIL-13, or rmIL-4 at 10 ng/ml. Cells were imaged every 24 h using a Nikon HCA fluorescence microscope. c Ear11 expression
by peritoneal macrophages cultured as indicated (in b) for 72 h, assessed by qPCR. Cells from 20 pooled mice, two wells/condition. d Ear11
protein concentration in cultures (as in b) assessed by ELISA. Data representative of two independent experiments. e Ear11 expression in
sorted alveolar macrophages and f, g total lung neutrophil numbers as assessed by flow cytometry, following two consecutive intranasal
doses of IL-25 or IL-25 and Ear11. Data pooled from two independent experiments (n= 4–6 per experiment).
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(Fig. 5e, f). Recruitment of eosinophils to the lung in both IL-25
and RWP challenges was completely independent of Ear11 (data
not shown). In addition, Muc5ac (but not Muc5b) expression in the
lungs in response to RWP, assessed as an indicator of mucus
production, was decreased in the absence of Ear11 (Fig. 5g).
In vitro assays have led to the proposal that human RNases have
anti-helminthic properties.29 To investigate the potential in vivo
role of Ear11 in gut-induced type-2 immunity to parasitic helminth
infection, wild-type and Ear11Ch/Ch mice were challenged with N.
brasiliensis larvae. Ear11-deficiency did not alter worm infectivity,
cellular infiltration including neutrophils, or cytokine production as
compared with wild-type controls in an acute infection model
(Supplementary Fig. 7a–c). Furthermore, in a N. brasiliensis-
induced model of type-2 immune response resolution, in which
lung tissues were analysed 32 days post infection, the numbers of
macrophages and eosinophils were normal in Ear11-deficient
mice. However, neutrophils were found to be reduced in number
in Ear11Ch/Ch mice (Supplementary Fig. 7d).
We hypothesised that other members of the Ear gene family
may be upregulated during type-2 inflammation and be partially
compensating functionally for the loss of Ear11 (e.g. normal worm
clearance and recruitment to some extent of neutrophils). The
RNase genes are located in two regions on mouse chromosome
14 (Supplementary Fig. 8a). We compared gene expression levels
of known members of the Ear gene family (Ang, Ear1, Ear2, Ear5,
Ear6, Ear10, and Ear14) in the lungs of wild-type and Ear11Ch/Ch
mice (data not shown). Notably, Ang, a gene closely related to
Ear11, was found to be more highly expressed in the lungs of
Ear11Ch/Ch mice as compared with lung samples from wild-type
mice (Supplementary Fig. 8b). These data demonstrate that the
expression of Angiogenin increases in the absence of Ear11 raising
the possibility that Ear11 and Ang genes may have redundant
roles in inducing aspects of type-2 immunity.
Together these results indicate that Ear11 contributes to the
homoeostasis of neutrophil numbers in normal tissues and helps
regulate neutrophil recruitment in response to type-2 immunity-
inducing agents. However, despite being highly upregulated by IL-
25, RWP and N. brasiliensis, in vivo, we were unable to demonstrate
an essential role for Ear11 in type-2 inflammation.
Recombinant Ear11 provokes macrophage and neutrophil
recruitment to the peritoneum
To determine the potential mechanism underlying the in vivo role
of Ear11 in regulating neutrophils, a single dose of rmEar11
protein (Supplementary Fig. 4a, b), was administered intraper-
itoneally to mice before harvesting peritoneal lavage (PEL) cells
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Fig. 5 Ear11 helps maintain both naive and type-2 dependent tissue neutrophilia. Flow cytometric analysis of total neutrophil numbers in
a the lung and spleen, (data pooled from 3 independent experiments, n= 3–6 per experiment), blood (data pooled from three independent
experiments, n= 10–20 per experiment), and b bone marrow (representative of two independent experiments, n= 6) of naive Ear11+/+ and
Ear11Ch/Ch mice. c Total number of lung and spleen macrophages in naive Ear11+/+ and Ear11Ch/Ch mice. d Total number of lung neutrophils in
mice treated intranasally with either PBS or IL-25. e Total number of lung macrophages in mice treated intranasally with PBS or RWP. f Total
number of lung neutrophils in mice treated intranasally with either PBS or RWP. g Quantitative PCR analysis of Muc5ac and Muc5b in lung
tissue from e. c–g Data representative of two independent experiments, n= 5–10 per experiment.
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3 h later. This resulted in the rmEar11-dependent infiltration of
CD45+Ly6GhighSiglecF− cells that included neutrophils, as com-
pared with PBS controls (Fig. 6a–c). Additional cell surface markers
confirmed that rmEar11 recruited predominantly Ly6GhighSi-
glecF−CD11b+F4/80−MHCII−SSClow neutrophils and to a lesser
extent Ly6GhighSiglecF−CD11b+F4/80+MHCII+SSChigh macro-
phages (Fig. 6d). Furthermore, histological analysis of purified
Ear11-induced Ly6GhighSiglecF− cells confirmed the infiltrate to be
composed of ~70% neutrophils and ~30%macrophages (Fig. 6b–d
and data not shown). The neutrophil-recruiting activity of
rmEar11 was heat labile being lost when the rmEar11 protein
was denatured, indicating that potential contamination with heat
stable LPS was not responsible for the cellular infiltration
(Fig. 6a–c). Interestingly, Ear11 was almost as potent at inducing
neutrophil infiltration, as the neutrophil chemoattractant,
CXCL1, that is a product characteristic of CAMs (Fig. 6a–d).
Together, these results demonstrate that Ear11 provokes
neutrophil, and to a lesser degree, macrophage recruitment,
which appears to be similar in nature to the infiltrate induced
following treatment with the CAM-associated CXCL1. However,
Ear11 and CXCL1 were observed to be reciprocally expressed
following challenge of mice with either LPS or RWP, with Ear11
characteristic of the type-2 immune response initiated by RWP,
and CXCL11 elicited by the type-1 stimulant LPS (Fig. 6e),
suggesting that they would each elicit their neutrophilic effect
as part of different types of immunological response. Indeed,
CXCL1 expression was unchanged in sorted macrophages taken
from Il7raCre control mice and ILC2-deficient mice treated
intranasally with IL-25 (Fig. 6f).
Ear11 induces chemokinetic movement of neutrophils in the
peritoneum
To directly assess the ability of Ear11 to induce chemotaxis or
chemokinesis of cells,39 within the Ly6GhighSiglecF− cell popula-
tion, in vitro transwell migration assays were performed. To avoid
cellular activation through Ly6G ligation during cell purification,
Fig. 6 Intraperitoneal administration of rmEar11 induces neutrophil and macrophage recruitment. a Flow cytometric analysis of
peritoneal lavage cells from naive BALB/c mice treated (native or denatured (DN) protein) as shown (dot plots gated on LiveCD45+ cells), and
b cytospin and Giemsa staining (representative images at ×100 magnification, 20 μm scale bar). c Quantification of Ly6G+SiglecF− cells from
flow cytometry by fixed volume count and of polymorphonuclear leucocytes by differential count (cytospin, bottom panel). Data
representative of three independent experiments (n= 3–4). d Phenotypic analysis of Ly6GhighSiglecF− cells using CD11b, F4/80, MHCII, and
FSC vs. SSC. Cells identified by flow cytometry in the Ly6GhighSiglecF− gate as ‘macrophage’ coloured blue and as ‘neutrophil’ coloured red. e
Ratio of Ear11 and Cxcl1 gene expression from purified lung macrophages from wild-type mice challenged with ragweed pollen (RWP) or LPS.
f Cxcl1 expression in sorted lung macrophages following two consecutive intranasal doses of IL-25. Data pooled from two independent
experiments (n= 4–5).
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the anti-Ly6G antibody staining was omitted and the total
macrophage- and neutrophil-containing CD45+CD11b+ cell
population was FACS purified from blood (Fig. 7a) and the
migration of these previously unstimulated cells, through a
transwell membrane, assessed over a 2-h period in response to
Ear11. Although migration was detected this was not restricted
to neutrophils, but included CD45+CD11b+Ly6G– cells, and was
not augmented by the presence of Ear11 in the bottom well
(Fig. 7b). These data suggest that Ear11 is not a chemotactic
factor but is likely to be chemokinetic, i.e. it promotes the
general non-directional migration of cells.39
To further address this possibility, we purified the
total intraperitoneal macrophage- and neutrophil-containing
CD45+CD11b+ cell population from mice 3 h after treatment of
mice with either PBS or Ear11 (Fig. 7c). Cell migration through a
transwell membrane over a 2-h period was determined in
response to media alone or Ear11 in the bottom chamber. In
the absence of exogenous Ear11 provocation of the mice, very few
Ly6GhighSiglecF– cells were present in the CD45+CD11b+ cell
fraction purified from PBS-treated PEL. Consequently, the in vitro
migration assays contained too few cells for meaningful analysis
(Fig. 7d, e). However, pre-treatment of mice with Ear11 resulted in
the marked increase of CD45+CD11b+Ly6GhighSiglecF– cells in the
PEL, that were purified for assessment in migration assays.
Interestingly, prior treatment of mice with Ear11 resulted in
preferential migration of CD45+CD11b+Ly6GhighSiglecF– neutro-
phils through the membrane (Fig. 7d). In contrast, despite the
presence of CD45+CD11b+Ly6G– cells in the CD45+CD11b+ cell
population in the upper chamber these macrophages did not
migrate under these conditions (data not shown). Notably,
neutrophil migration was not increased with the inclusion of
Ear11 in the lower chamber as compared with media alone
controls (Fig. 7d, e), further suggesting that a ‘chemokinetic
migratory’ neutrophil phenotype was induced in the neutrophils
recruited to the peritoneum by in vivo treatment with Ear11.
Taken together the results demonstrate that Ear11 can provoke
increased motility in neutrophils, suggesting that AAMs secreting
Ear11 can act to mobilise neutrophils.
DISCUSSION
Type-2 immunity is characterised by a predominant eosinophilia and
the appearance of AAMs, and whilst neutrophils are present they are
relatively fewer in number. In part this is because AAMs, in contrast
to CAMs, do not express chemoattractants such as CXCL1 that
typically drive neutrophil recruitment.40,41 Our data suggest that
Ear11 production predominantly from monocytes, AAMs, and
alternatively activated DCs, contributes to maintaining neutrophil
numbers in tissues during homoeostasis, and following type-2
immune activation. In the case of type-2 responses this is at least
partially dependent on ILC2. Thus, in an IL-25 driven type-2 immune
microenvironment an alternate Ear11-mediated mechanism has
arisen to ensure that neutrophils can contribute to the immune
reaction without the requirement for TLR and IFN-γ stimulated
CAM-derived neutrophil chemoattractants and the escalation of an
unwanted and counter-productive pro-inflammatory response.
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Fig. 7 Ear11 mobilises peritoneal neutrophils. a Naive LiveCD45+CD11b+ cells were sorted from blood, and stained with Ly6G and SiglecF
to show the presence of neutrophils (Ly6GhighSiglecF−). b Sorted LiveCD45+CD11b+ cells were cultured in an in vitro transwell system with or
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In the mouse, a large family of small ribonucleases (Ear) show
notable sequence and structural homology to human EDN and
ECP.42–44 The secreted Ear proteins are characterised by an N-
terminal signal peptide followed by a ribonuclease A domain
containing conserved catalytic histidines and a lysine.45 Mouse Ear11
(also known as Rnase2a) transcripts are expressed at basal levels in
naive tissues, but can be highly upregulated in response to type-2
immune activation.35 Indeed, Ear11 expression has been shown to
be elicited in lung alveolar macrophages following the induction of
ovalbumin-induced airways inflammation,38 and in response to
short and long-term mouse models of allergic asthma.46,47 Similarly,
administration of the type-2 initiator cytokines IL-25 or IL-33 also
induced Ear11 gene expression.34,35 Although most members of this
RNase A gene family have not been studied extensively, a recent
report indicated that Ear11 may function in vitro as a chemoat-
tractant for tissue macrophages independently of TLR2 signalling.35
Although macrophages represent a spectrum of phenotypes
influenced by local environmental cues and stimuli, distinct
polarised subsets have been described.10 CAMs arise in response
to stimulation via IFN-γ and TLR ligation leading to their
production of inflammatory cytokines, nitric oxide, and chemo-
kines such as CXCL1 that recruit neutrophils to sites of microbial
infection. By contrast, the type-2 cytokines IL-4 and IL-13 support
AAMs that are often considered anti-inflammatory, promoting
quiescence and repair, and restricting inflammatory responses
characterised by CAMs. This response helps to restore the damage
resulting from parasitic worm invasion, but may lead to
inappropriate tissue repair and fibrosis in allergic disease.
Macrophages exhibiting an AAM phenotype (also known as M2
or M(IL-4)), characterised by the expression of high levels of Relma
and Arg1, have been reported in multiple tissues,48 suggesting a
broad physiological role, possibly in maintaining immune homo-
eostasis and preventing unwanted inflammation. Indeed, tissue-
resident ILC2s have been shown to produce IL-4 and IL-13 that
sustain AAMs for the establishment of inflammatory thresholds in
neonate and adult lungs,49 and in adipose tissue to protect from
obesity.50 Such an environment may be maintained through
tissue-resident macrophages self-renewing and proliferating in
response to IL-4 without additional recruitment.51
Using a new Ear11Ch/+ knock-in reporter mouse, we demon-
strated Ear11 expression in vivo across multiple tissues, cell types,
and models of immune activation. Ear11 was highly restricted
to monocytes (CD11b+ Ly6C+ CD115+), dendritic cells
(CD11c+MHCIIhigh), and macrophages (CD11b+F4/80+) and was
only induced by type-2 cytokines, allergic challenges, and parasitic
infection, but not by pneumoviral (PVM) infection or bacterial
(LPS) provocation. Although Ear11 expression was induced by IL-
25 and IL-33 in vivo, these cytokines did not upregulate Ear11
production directly from macrophages, but instead this required
IL-4, in line with a report that IL-4 provoked Ear11 transcripts from
alveolar macrophages.35 AAMs are induced in an IL-4Rα1- and
STAT6-dependent manner and are characterised by expression of
molecules including the mannose receptor, Ym1, Arg1, Relma, and
Fizz1.52–54 Our in vivo analysis has established that Ear11
expression was limited to Relmα-positive AAMs. This discovery
prompts the future investigation of the syntenic human mole-
cules, EDN and ECP, which may have as yet unappreciated roles in
AAM biology and indeed these molecules do seem to be
expressed at low levels in RNASeq datasets taken from human
AAM cultures.55
Exploiting several complementary approaches, including Ear11
overexpression in transgenic mice, Ear11 ablation and exogenous
Ear11 administration, we demonstrate here that Ear11 is a
monocyte- and AAM-secreted regulator of neutrophil homoeostasis
and migration. Consequently, Ear11-enhanced neutrophil recruit-
ment to tissues, such as lung and spleen, was compromised in
Ear11-deficient mice. Conversely, mice overexpressing Ear11, had
increased neutrophil infiltration to peripheral tissues, but not in
bone marrow, perhaps reflecting the normal constitutive naive
expression of Ear11 here. In addition, when rmEar11 protein was
given to mice it provoked a predominantly neutrophilic cell
infiltration, and to a lesser extent macrophage recruitment, within
3 h of its administration. However, administration of Ear11 to
ILC2-deficient mice was not sufficient to promote recruitment of
neutrophils, suggesting that further, yet to be defined factors are
also necessary. Taken together, these results demonstrate that
Ear11 production by AAMs represents a novel mechanism for
neutrophil maintenance and recruitment to sites of type-2
immunity. Though the role of neutrophils in type-2 immune
responses remains controversial, it has been shown that an early
migration of neutrophils to the site of infection is necessary to
control worm burden.19,56,57 Our data using alarmin- and allergen-
induced type-2 models support these previous observations.
However, other studies suggest production of Th2-derived IL-4
and IL-13 later in the type-2 response can also inhibit neutrophi-
lia.58–60 Our data suggest that early IL-4 production, from cell types
such as ILC2s, may be required for timely neutrophil infiltration.
Thus, these apparently contradictory observations may be recon-
ciled by considering a differential involvement of neutrophils in
different stages of the type-2 response.61
Interestingly, in naive Ear11-deficient mice there were also
fewer neutrophils in the tissues and fewer neutrophil progenitors
in the bone marrow, suggesting that in the steady state Ear11
helps to maintain homoeostatic numbers of neutrophils. Further
studies are required to determine whether this results from effects
on development, proliferation, or survival (or a combination of the
three). Ear11 may therefore poise neutrophil infiltration in a
manner similar to the way that IL-5 and eotaxin regulate
eosinophils.62–64 The precise pathways required to maintain
neutrophils at tissue sites during homoeostasis are not well
characterised, but the rate of neutrophil production, storage in
and egress from the bone marrow, and survival in, and movement
out of the blood are all proposed to play a role in this
‘neutrostat’.65 Our results suggest that Ear11 production by
monocytes and AAMs contributes to this process. Interestingly,
Ear11 is part of a family of RNases and we noted that in the
absence of Ear11 the highly related molecules Angiogenin was
upregulated, suggesting that compensatory mechanisms may
arise between members of this family. Thus, it may be necessary to
remove two or more of these genes to fully explore the impact of
RNase-regulated neutrophil induction on immune function.
The rapid influx of neutrophils following intraperitoneal
injection of rmEar11 clearly demonstrated its capacity to stimulate
neutrophil, and to a lesser extent macrophage, recruitment to the
peritoneal cavity. Notably, the migratory effect of Ear11 was only
marginally less potent than exogenously administered CXCL1.
Interestingly, when we harvested cells from the peritoneal lavage
of Ear11-provoked mice we found that the neutrophil component
was highly migratory in vitro, whilst these assays were unable to
detect macrophages migrating in the same time-frame. It is also
noteworthy that once activated in vivo the neutrophils did not
respond chemotactically to additional Ear11 provided in the assay
system, implying that they are responding chemokinetically to
Ear11. These assays could only be performed using cells from
Ear11-stimulated mice since these populations were absent from
the peritoneal lavage in the absence of Ear11 provocation. In vitro
studies carried out previously suggested that rmEar11 provided a
chemoattractant signal to naive F4/80+CD11c− macrophages
within the total splenocyte population assayed, with little effect
on Ly6G+ cells.35 However, we now demonstrate that in vivo the
main cell target of Ear11-induced migration is neutrophils, with a
lesser but still significant contribution to macrophage recruitment.
This difference between the two studies may result from the tissue
source of the cells under study (e.g. spleen versus peritoneal
lavage) and the importance of maintaining tissue and cellular
environments using in vivo approaches.
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In conclusion, we have demonstrated a novel in vivo role for
Ear11, a close relative of human ECP and EDN proteins, in neutrophil
recruitment and maintenance in tissues. Consequently, Ear11
produced by IL-4-activated AAMs as part of type-2 immune
reactions, is exquisitely placed to support the infiltration of
neutrophils in response to immune challenges that fail to elicit
CXCL1-producing pro-inflammatory CAM (Supplementary Fig. 9).
Our data also raise the possibility that human RNase molecules may
have similar roles in humans and contribute to neutrophilic asthma.
METHODS
Mice
Overexpression of Ear11 (Rnase2a) in all tissues was achieved by
microinjection of wild-type Ear11 cDNA, under the transcriptional
control of CAG promoter in the pCAGGS vector (Supplementary
Table 1), into F1 fertilised eggs. Two founder Ear11 transgenic (Tg)
lines were identified. Ear11Tg mice did not breed and in vitro
fertilisation was used to maintain two of the founder lines (mouse
identifier 64572 and 71970).
Ear11mCherry reporter mice (Ear11Ch/Ch) mice were generated
by replacing exon 2 of Ear11 with the mCherry fluorescent protein
coding sequence followed by a floxed neomycin resistance gene
in JM8.6 (C57BL/6) embryonic stem cells by homologous
recombination. Embryonic stem cell clones in which a successful
targeting event had occurred were identified using 5′ and 3′
probes (Supplementary Table 1) by Southern blot analysis and
used to generate Ear11+/Ch mice. The neomycin gene was
removed in the germline by interbreeding Ear11Ch/Ch with a Cre-
recombinase expressing strain. The line was then also backcrossed
onto the BALB/c background for six generations.
For bone marrow transfer experiments B6SJL (CD45.1) mice
were sub-lethally irradiated with two doses of 4.5 Gy γ-irradiation.
On the same day they received 1–2 × 106 bone marrow cells (fresh
or frozen stocks), from either C57BL/6 (CD45.2) or Ear11Tg
(CD45.2) mice, by intravenous injection. Mice were reconstituted
for at least 6 weeks.
Il7raCre and Roraf/fIl7raCre mice are previously described.8 Age-
and sex-matched mice at 6 weeks old or above were used in
experiments. Mice were housed in specific pathogen-free condi-
tions. All experiments were undertaken with the approval of the
UK Home Office.
Generation of rmEar11 protein and anti-mouse Ear11 antibodies
Recombinant mouse (rm)Ear11 was expressed as a 6xHis fusion
protein in Sf9 cells using Bac-to-Bac Baculovirus Expression System
(Thermo Fisher Scientific) and purified from cell culture super-
natants on a Nickel NTA resin column (GE Healthcare) followed by
gel filtration on HiLoad 16/60 Superdex 75 column (GE Healthcare)
and then HisTrap HP column (GE Healthcare). Purified protein was
dialysed into sterile, endotoxin-free PBS. Endotoxin concentration
was quantified at 32 EU/mg using the Limulus/Amebocyte Lysate
(LAL) assay according to manufacturer’s instructions (Pierce,
ThermoFisher).
A male rat was immunised by sub-cutaneous injection of 100 μg
of rmEar11 combined in a 1:1 ratio with TiterMax (Sigma-Aldrich)
on day 0, 28, and 32. A single intravenous injection of 50 μg of
Ear11 was given on day 84. Monoclonal antibodies were
generated by standard protocols.
Ear11 protein detection
Ear11 levels in supernatants were assessed using a Meso Scale
Diagnostics (MSD) assay. MSD standard binding plates (Meso Scale
Diagnostics) were coated with polyclonal anti-Ear11 serum (1:2500
dilution), blocked with 5% Blocker A (Meso Scale Diagnostics) and
incubated with standards (serial dilution of rmEar11) and/or samples
overnight. Detection antibody, biotinylated monoclonal rat anti-
mouse Ear11 antibody (clone BC2.12), was added at 2 μg/ml,
followed by streptavidin SULFO-TAG (Meso Scale Diagnostics) and
2x Read buffer T (Meso Scale Diagnostics). The electrochemilumi-
nescent signal was read on a Sector S 600 plate reader.
Mouse challenge protocols
In all instances recombinant proteins, extracts, and LPS were given
in endotoxin-free PBS (Sigma-Aldrich) or PBS as a control.
rmIL-25 (2 μg/dose, made in-house, Janssen Pharmaceuticals),
rmIL-33 (0.5 μg/dose, Peprotech) or rmEar11 (2 μg/dose) were given
on 2 or 3 consecutive days (as indicated) and tissues harvested 24 h
after the final dose. rmEar11 (2 μg/dose) or CXCL1 (0.5 μg/ml, R and
D Systems; <100 EU/mg protein) were given as a single dose and
tissues were harvested at 12 h post injection. rmEar11 and CXCL1
were boiled for 60min to denature the protein.
RWP (100–200 μg/dose, RWP, Ambrosia artemisiifolia, short form,
Greer Laboratories) was given intranasally on 5 consecutive days.
All tissues were harvested 24 h after the final dose. Alternatively,
three doses RWP were administered intranasally over 3 days and
lung CD45+CD11c+F4/80+SiglecF+ alveolar macrophages purified
24 h after the final dose. Macrophage gene expression was
analysed by qPCR.
LPS (1–2 μg/dose, Ultrapure LPS-EB from Escherichia coli 0111:
B4, InvivoGen) was given intranasally on three consecutive days.
Analyses were performed 24 h after the final dose. In some
experiments, lung CD45+CD11c+F4/80+SiglecF+ alveolar macro-
phages were purified and gene expression analysed by qPCR.
Mouse Infection models
Mice were inoculated sub-cutaneously with 500 viable third-stage
N. brasiliensis larvae in endotoxin-free PBS and tissues were
harvested on day 4, 7, 10, and 32 post infection.
A single intranasal dose of 50 PFU of PVM (strain J3666, gift from
Prof. Easton) was given in PBS or PBS alone. Tissues were analysed
at day 2, 5, and 12 post infection.
Cell preparation and flow cytometry
Single lung cell suspensions were prepared by incubating finely
chopped tissue with 720 μg/ml collagenase D (Roche) in RPMI
(Invitrogen) at 37 °C for 30 min, passing the tissue through a 70 μm
cell strainer, centrifugation through 30% Percoll (GE Healthcare) in
RPMI and lysing RBCs. Single spleen, mediastinal, and mesenteric
lymph node cell suspensions were prepared by passing the tissue
through a 70 μM cell strainer (except when preparing cells for
macrophage subpopulation analysis where tissue was treated with
collagenase D, as for lung) and lysing RBCs. Single bone marrow
and peritoneal cell suspensions were prepared by flushing the
femur and tibia, or peritoneum with endotoxin-free PBS and lysing
RBCs. Peripheral blood leukocytes were prepared using Whole
Blood Lysing Reagent Kit (Beckman Coulter) according to the
manufacturer’s instructions.
Single cell suspensions were incubated with anti-CD16/CD32
antibody (Fc block, clone 93) followed by fluorochrome-conjugated
antibodies (Biolegend, unless otherwise indicated) against: mouse
Arginase 1 (A1exF5), B220 (clone RA3-6B2), CD3 (clone 145-2C11),
CD4 (clone H129.19, BD Biosciences), CD8 (clone 53–6.7), CD11b
(clone M1/70), CD11c (clone N418), CD19 (clone eBio 1D3), CD45
(clone 30-F11), CD45.1 (clone A20), CD45.2 (clone 104), CD115 (clone
AFS98), CD127 (clone SB/199), F4/80 (clone BM8), FcεR1 (clone MAR-
1), Gr-1 (RB6–8C5), ICOS (clone 398.4A), Ly6C (clone HK1.4), Ly6G
(clone 1A8-Ly6g), MHCII (M5/114.15.2, Biolegend), Relmα (DS8RELM,
eBioscience), SiglecF (E50-2440, BD Biosciences). All samples were
co-stained with a cell viability dye (Fixable dye eFluor780,
Invitrogen). For analysis samples were run on an LSR Fortessa
system (BD Biosciences). For cell sorting an iCyt Synergy (70 μm
nozzle, Sony Biotechnology) was used.
Unless otherwise stated alveolar macrophages were defined as
CD45+CD11c+F4/80+SiglecF+, eosinophils as CD45+CD11c−F4/
80−CD11b+Gr1int SiglecF+, neutrophils as CD45+CD11c−F4/
Group-2 innate lymphoid cell-dependent regulation of tissue neutrophil. . .
V Panova et al.
10
Mucosal Immunology _#####################_
80−CD11b+Gr1highSiglecF−, CD4+ T cells as CD45+ CD3+CD4+,
and innate lymphoid type-2 cells (ILC2s) as CD45+Lin−
(CD3CD4CD8CD19 CD11bCD11cFcεR1) CD127+ICOS+.
Immunofluorescence imaging
Lung and FALC were prepared by fixation in 4% paraformalde-
hyde at 4 °C for 1 h, incubating in 20% sucrose overnight for
cryoprotection, and embedding in 15% sucrose/7.5% gelatin
diluted in PBS. Overall, 12 μm frozen sections were cut using a
Leica CM 3050 S cryostat. Sections were pre-blocked/permeabi-
lized in PBS containing 3% BSA and 0.05% Triton X-100 and
stained with primary antibodies anti-mCherry (M11217, Invitro-
gen), anti-Relmα (500-P214, PeproTech), or anti-actin α-smooth
muscle FITC conjugated (1A4, Sigma), followed by secondary
antibodies anti-rat IgG Alexa Fluor 568 (A11077, Life Technologies)
and anti-rabbit IgG Alexa Fluor 488 (A21206, Life Technologies) for
1 h at the room temperature, or directly conjugated CD3 (clone
145-2C11), B220 (clone RA3-6B2), and CD169 (clone 3D6.112).
Image acquisition was performed using either a Zeiss LSM 780
confocal microscope and ZEN 2010 acquisition software or a
Nikon HCA fluorescence microscope and NIS-Elements 4.30.01
acquisition software for live cell imaging. Adobe Photoshop 11.0.2
was used to adjust brightness, contrast and colour balance
(changes were applied to all images in equal measure).
In vitro culture of primary cells
Sorted peritoneal macrophages were cultured for 72 h in RPMI
media (Gibco) with 10% fetal bovine serum (Labtech), 1%
penicillin/streptomycin and 100 μM 2-β-mercaptoethanol (BDH
Biochemicals) with or without 10 ng/ml IL-33 (Biolegend), 10 ng/
ml IL-25 (Janssen), 10 ng/ml IL-13 (eBioscience), or 10 ng/ml IL-4
(R&D Systems). Cell free supernatants were collected for ELISA and
cells were lysed using Trizol LS reagent (Life Technologies) for RNA
extraction.
Cells were flushed from the bone marrow through a 70 μm cell
strainer and incubated with the following fluorochrome-conjugated
antibodies against: CD5 (clone 53–7.3), CD117 (clone 2B8), Sca1
(clone D7), CD34 (clone RAM34), CD16/32 (clone 93), as well as
lineage markers as previously described (CD11b, B220, Gr1, TER119,
CD19). Fixable viability dye eFluor780 (Invitrogen) was also added.
CMP cells were then sorted as LiveLineage−CD5−CD117+S-
ca1−CD16/32intCD34+ and plated at 100 cells/well in MethoCultTM
with GF M3434 media (STEMCELL Technologies). Colony number
and type were analysed at day 9 using the STEMvision system with
the custom mouse CSC algorithm.
Live CD45+CD11b+ cells were sorted from peritoneal lavage of
PBS- and Ear11-treated mice, or from naive blood and plated on
24 well transwell inserts (PET, 3.0 μm pore, Falcon) at between 2.5
and 3.0 × 105 cells/well. Media alone or 10 ng/ml rmEar11 was
added to the bottom well and cells were incubated at 37 °C for 2
h, after which cells that had migrated through the membrane
were subject to flow cytometry.
Reverse-transcription (RT)-PCR and real-time quantitative (q) PCR
RNA was isolated using RNA Bee reagent (Amsbio) or Trizol LS
reagent (Life Technologies) according to the manufacturer’s
instructions. All RNA samples were treated with DNase I using
RNeasy Micro Kit (Qiagen) and reverse-transcribed into comple-
mentary DNA using Super-RT enzyme (HT Biotechnology). RT-PCR
was performed using KOD Hot Start DNA polymerase (Novagen)
and self-designed primers (Table S1). Products were run on a 2%
agarose gel and visualised using a Bio-Rad ChemiDoc XRS+
System and Image Lab 5 software. Real-time qPCR was performed
using SYBR Green mastermix (Applied Biosystems) and self-
designed primers or Taqman Universal PCR master mix (Applied
Biosystems) and commercially available Taqman gene expression
assays (Table S1, Applied Biosystems). Samples were run on the
ViiA7 real-time PCR system (Applied Biosystems).
Histology
Tissue was fixed in 10% formalin overnight and paraffin-embedded.
Sections were stained with haematoxylin and eosin. Image
acquisition was performed using a Nikon Labophot-2 biological
microscope and Camera Control Pro 2 software. Peritoneal lavage
cells were subject to cytospin and differential counting.
Statistical analyses
Results are shown as mean ± SEM. Results were considered
significant at *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001; ****P ≤ 0.0001.
Statistical analyses were performed using Prism version 6.0f.
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